Laddar...
Addition of DHA synergistically enhances the efficacy of regorafenib for kidney cancer therapy
Kidney cancer is the 6(th) most common cancer in the US and its incidence is increasing. The treatment of this malignancy took a major step forward with the recent introduction of targeted therapeutics such as the kinase inhibitors. Unfortunately, kinase inhibition is associated with the onset of re...
Sparad:
| I publikationen: | Mol Cancer Ther |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4873345/ https://ncbi.nlm.nih.gov/pubmed/26921392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0847 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|